Goodwill and Other Intangible Assets (Tables)

9 Months Ended

Mar. 31, 2012

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Goodwill [Table Text Block]

Changes in the carrying amount of goodwill, by reportable segment, were as follows:

	Consumer Healthcare			Nutritionals		Rx Pharmaceuticals			API			Total
Balance as of June 25, 2011	$	126,309		$	331,744	$	81,631		$	98,361		$	638,045
Business acquisitions	15,040			—		148,865			—			163,905
Currency translation adjustment	(706		)	—		(5,880		)	(7,156		)	(13,742		)
Balance as of March 31, 2012	$	140,643		$	331,744	$	224,616		$	91,205		$	788,208

Schedule of Finite and Indefinite-Lived Intangible Assets [Table Text Block]

Other intangible assets and related accumulated amortization consisted of the following:

	March 31, 2012				June 25, 2011				March 26, 2011
	Gross		Accumulated Amortization		Gross		Accumulated Amortization		Gross		Accumulated Amortization
Amortizable intangibles:
Developed product technology/formulation and product rights	$	549,356	$	131,815	$	328,461	$	101,494	$	323,504	$	92,540
Customer relationships	342,405		46,259		331,081		32,029		331,501		28,077
Distribution and license agreements	53,004		22,838		52,790		19,844		51,794		18,591
Non-compete agreements	7,853		3,419		6,391		2,431		6,488		2,138
Trademarks	5,026		713		5,378		730		5,223		728
Total	957,644		205,044		724,101		156,528		718,510		142,074
Non-amortizable intangibles:
In-process research and development	35,000		—		—		—		—		—
Trade names and trademarks	7,481		—		6,857		—		6,868		—
Total intangibles	$	1,000,125	$	205,044	$	730,958	$	156,528	$	725,378	$	142,074

Schedule of Intangible Assets, Future Amortization Expense [Table Text Block]

The estimated amortization expense for each of the following five years is as follows:

Fiscal Year	Amount
2012(1)	$	18,600
2013	75,700
2014	75,600
2015	74,900
2016	72,800

⁽¹⁾Reflects remaining three months of fiscal 2012.